Literature DB >> 22810088

Epigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetes.

Elizabeth R Gilbert1, Dongmin Liu.   

Abstract

Type 2 diabetes (T2D) is a growing health problem worldwide. While peripheral insulin resistance is common during obesity and aging in both animals and people, progression to T2D is largely due to insulin secretory dysfunction and significant apoptosis of functional β-cells, leading to an inability to compensate for insulin resistance. It is recognized that environmental factors and nutrition play an important role in the pathogenesis of diabetes. However, our knowledge surrounding molecular mechanisms by which these factors trigger β-cell dysfunction and diabetes is still limited. Recent discoveries raise the possibility that epigenetic changes in response to environmental stimuli may play an important role in the development of diabetes. In this paper, we review emerging knowledge regarding epigenetic mechanisms that may be involved in β-cell dysfunction and pathogenesis of diabetes, including the role of nutrition, oxidative stress and inflammation. We will mainly focus on the role of DNA methylation and histone modifications but will also briefly review data on miRNA effects on the pancreatic islets. Further studies aimed at better understanding how epigenetic regulation of gene expression controls β-cell function may reveal potential therapeutic targets for prevention and treatment of diabetes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22810088      PMCID: PMC3427279          DOI: 10.4161/epi.21238

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  123 in total

1.  Control of pancreatic β cell regeneration by glucose metabolism.

Authors:  Shay Porat; Noa Weinberg-Corem; Sharona Tornovsky-Babaey; Rachel Schyr-Ben-Haroush; Ayat Hija; Miri Stolovich-Rain; Daniela Dadon; Zvi Granot; Vered Ben-Hur; Peter White; Christophe A Girard; Rotem Karni; Klaus H Kaestner; Frances M Ashcroft; Mark A Magnuson; Ann Saada; Joseph Grimsby; Benjamin Glaser; Yuval Dor
Journal:  Cell Metab       Date:  2011-04-06       Impact factor: 27.287

2.  miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1).

Authors:  Timothy J Pullen; Gabriela da Silva Xavier; Gavin Kelsey; Guy A Rutter
Journal:  Mol Cell Biol       Date:  2011-06-06       Impact factor: 4.272

Review 3.  Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

Authors:  Per Westermark; Arne Andersson; Gunilla T Westermark
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

Review 4.  Advanced glycation end products.

Authors:  Merlin C Thomas
Journal:  Contrib Nephrol       Date:  2011-06-09       Impact factor: 1.580

5.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Authors:  Seth L Masters; Aisling Dunne; Shoba L Subramanian; Rebecca L Hull; Gillian M Tannahill; Fiona A Sharp; Christine Becker; Luigi Franchi; Eiji Yoshihara; Zhe Chen; Niamh Mullooly; Lisa A Mielke; James Harris; Rebecca C Coll; Kingston H G Mills; K Hun Mok; Philip Newsholme; Gabriel Nuñez; Junji Yodoi; Steven E Kahn; Ed C Lavelle; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2010-09-12       Impact factor: 25.606

Review 6.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

7.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

8.  Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1.

Authors:  Jun H Park; Doris A Stoffers; Robert D Nicholls; Rebecca A Simmons
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 9.  Role of metabolic programming in the pathogenesis of beta-cell failure in postnatal life.

Authors:  Rebecca A Simmons
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

10.  Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome.

Authors:  Dana C Dolinoy; Jennifer R Weidman; Robert A Waterland; Randy L Jirtle
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

View more
  50 in total

Review 1.  Genes affecting β-cell function in type 1 diabetes.

Authors:  Tina Fløyel; Simranjeet Kaur; Flemming Pociot
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

2.  Methylation of insulin DNA in response to proinflammatory cytokines during the progression of autoimmune diabetes in NOD mice.

Authors:  Jinxiu Rui; Songyan Deng; Jasmin Lebastchi; Pamela L Clark; Sahar Usmani-Brown; Kevan C Herold
Journal:  Diabetologia       Date:  2016-02-24       Impact factor: 10.122

3.  Causes and consequences of gestational diabetes in South Asians living in Canada: results from a prospective cohort study.

Authors:  Sonia S Anand; Milan Gupta; Koon K Teo; Karleen M Schulze; Dipika Desai; Nora Abdalla; Michael Zulyniak; Russell de Souza; Gita Wahi; Mateen Shaikh; Joseph Beyene; Eileen de Villa; Katherine Morrison; Sarah D McDonald; Hertzel Gerstein
Journal:  CMAJ Open       Date:  2017-08-09

Review 4.  The role of aging upon β cell turnover.

Authors:  Jake A Kushner
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

Review 5.  Epigenetic role of N6-methyladenosine (m6A) RNA methylation in the cardiovascular system.

Authors:  Kun Zhao; Chuan-Xi Yang; Peng Li; Wei Sun; Xiang-Qing Kong
Journal:  J Zhejiang Univ Sci B       Date:  2020-07       Impact factor: 3.066

Review 6.  Translational implications of the β-cell epigenome in diabetes mellitus.

Authors:  Justin S Johnson; Carmella Evans-Molina
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

7.  Epigenetic disruption and glucose homeostasis changes following low-dose maternal bisphenol A exposure.

Authors:  Huailong Chang; Danqi Wang; Wei Xia; Xinyun Pan; Wenqian Huo; Shunqing Xu; Yuanyuan Li
Journal:  Toxicol Res (Camb)       Date:  2016-06-20       Impact factor: 3.524

Review 8.  Artificial light at night: melatonin as a mediator between the environment and epigenome.

Authors:  Abraham Haim; Abed E Zubidat
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-05-05       Impact factor: 6.237

Review 9.  Diabetes mellitus and inflammation.

Authors:  Eric Lontchi-Yimagou; Eugene Sobngwi; Tandi E Matsha; Andre Pascal Kengne
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

Review 10.  Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis.

Authors:  Steven H Zeisel
Journal:  Clin Chem Lab Med       Date:  2013-03-01       Impact factor: 3.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.